EpiShuttle Approved in Australia!
EpiGuard is proud to announce that the EpiShuttle has been approved by the Therapeutic Goods Administration (TGA) and is now available for use in the Australian market!
EpiGuard is proud to announce that the EpiShuttle has been approved by the Therapeutic Goods Administration (TGA) and is now available for use in the Australian market!
EpiGuard’s commitment to safety and quality was attested by our successful completion of an audit by the Norwegian Medicines Agency last June.
It’s been an exciting summer at EpiGuard, with the launch of our new e-Learning platform and the appointment of our new CEO, Michael Eimstad.
Be prepared for next Disease X! EpiShuttle e-learning will make patient isolation and transportation safer and more efficient!
Finland is investing in the future safety of their citizens by increasing national preparedness for pandemics and CBRNe events with EpiShuttles!
EpiGuard is proud to announce a new exclusive partnership with Leader Healthcare Group!
EpiGuard has been ISO 13485:2016 certified for developing innovative solutions that are safe, high-quality, and effective.
FAI has obtained supplementary type certification (STC) for the EpiShuttle on the aircraft type CL-600 after undergoing tests on flammability, rapid decompression, and patient evacuation.
Epiguard has won Oslo Innovation award! This is a collaboration between the City of Oslo and Innovation Norway, and it is designed to highlight the companies that made an extraordinary impact on both business and society.
Når vi forlater pandemitåka må vi sitte igjen med mer enn et stikk fra legemiddelindustrien. Intensivavdelingene har slått alarm om dårlig beredskap. God beredskap handler ikke bare om bemanning, men også om ny teknologi og trening i skarpe situasjoner.